Log in
NYSE:CRY

CryoLife Stock Forecast, Price & News

$16.76
-0.61 (-3.51 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$16.60
Now: $16.76
$17.34
50-Day Range
$16.35
MA: $18.28
$19.89
52-Week Range
$12.63
Now: $16.76
$31.77
Volume199,721 shs
Average Volume302,508 shs
Market Capitalization$634.50 million
P/E RatioN/A
Dividend YieldN/A
Beta1.33
CryoLife, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company operates in two segments, Medical Devices and Preservation Services. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X mechanical heart valves; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products, a range of stent graft systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G, a stent graft system for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac, a stent graft used to treat aneurysmal iliac arteries, as well as aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers vascular preservation services; synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products, such as YAG laser consoles, related service and maintenance, and single-use, fiber-optic handpieces; and CryoVein femoral vein and CryoArtery femoral artery vascular preservation services for vascular access. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.
Read More
CryoLife logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.4Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.17 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP22890310
Phone770-419-3355
Employees1,200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$276.22 million
Cash Flow$0.69 per share
Book Value$7.62 per share

Profitability

Net Income$1.72 million

Miscellaneous

Market Cap$634.50 million
Next Earnings Date11/4/2020 (Confirmed)
OptionableOptionable
$16.76
-0.61 (-3.51 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CRY News and Ratings via Email

Sign-up to receive the latest news and ratings for CRY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











CryoLife (NYSE:CRY) Frequently Asked Questions

How has CryoLife's stock price been impacted by COVID-19 (Coronavirus)?

CryoLife's stock was trading at $23.87 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CRY shares have decreased by 29.8% and is now trading at $16.76.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of CryoLife?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoLife in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for CryoLife
.

When is CryoLife's next earnings date?

CryoLife is scheduled to release its next quarterly earnings announcement on Wednesday, November 4th 2020.
View our earnings forecast for CryoLife
.

How can I listen to CryoLife's earnings call?

CryoLife will be holding an earnings conference call on Wednesday, November 4th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were CryoLife's earnings last quarter?

CryoLife, Inc. (NYSE:CRY) announced its quarterly earnings data on Thursday, July, 30th. The medical equipment provider reported ($0.02) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.03) by $0.01. The medical equipment provider had revenue of $53.77 million for the quarter, compared to the consensus estimate of $51.30 million. CryoLife had a negative net margin of 4.33% and a positive return on equity of 0.96%.
View CryoLife's earnings history
.

What price target have analysts set for CRY?

5 analysts have issued 12-month price targets for CryoLife's shares. Their forecasts range from $25.00 to $29.00. On average, they expect CryoLife's share price to reach $27.50 in the next year. This suggests a possible upside of 64.1% from the stock's current price.
View analysts' price targets for CryoLife
.

Who are some of CryoLife's key competitors?

What other stocks do shareholders of CryoLife own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CryoLife investors own include Energy Transfer (ET), AT&T (T), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Enterprise Products Partners (EPD), Gilead Sciences (GILD), Netflix (NFLX), Zoetis (ZTS), Ares Capital (ARCC) and Edwards Lifesciences (EW).

Who are CryoLife's key executives?

CryoLife's management team includes the following people:
  • Mr. James Patrick Mackin, Chairman, Pres & CEO (Age 53, Pay $1.33M)
  • Mr. David Ashley Lee CPA, CPA, Exec. VP, COO & CFO (Age 55, Pay $712.66k)
  • Ms. Jean F. Holloway, Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec. (Age 63, Pay $551.04k)
  • Mr. John E. Davis, Sr. VP of Global Sales & Marketing (Age 55, Pay $514.88k)
  • Mr. Michael S. Simpson, Sr. VP of Regulatory Affairs & Quality Assurance (Age 52, Pay $571.22k)

What is CryoLife's stock symbol?

CryoLife trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRY."

Who are CryoLife's major shareholders?

CryoLife's stock is owned by many different institutional and retail investors. Top institutional investors include Exchange Traded Concepts LLC (0.08%), Candriam Luxembourg S.C.A. (0.08%), Louisiana State Employees Retirement System (0.05%), Dupont Capital Management Corp (0.04%) and BNP Paribas Arbitrage SA (0.02%). Company insiders that own CryoLife stock include Amy Horton, David Ashley Lee, James P Mackin, Jean F Holloway, John E Davis, Ronald D Mccall and Scott B Capps.
View institutional ownership trends for CryoLife
.

Which institutional investors are selling CryoLife stock?

CRY stock was sold by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., and Dupont Capital Management Corp. Company insiders that have sold CryoLife company stock in the last year include Jean F Holloway, Ronald D Mccall, and Scott B Capps.
View insider buying and selling activity for CryoLife
.

Which institutional investors are buying CryoLife stock?

CRY stock was acquired by a variety of institutional investors in the last quarter, including Exchange Traded Concepts LLC, Louisiana State Employees Retirement System, and BNP Paribas Arbitrage SA. Company insiders that have bought CryoLife stock in the last two years include James P Mackin, and John E Davis.
View insider buying and selling activity for CryoLife
.

How do I buy shares of CryoLife?

Shares of CRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is CryoLife's stock price today?

One share of CRY stock can currently be purchased for approximately $16.76.

How big of a company is CryoLife?

CryoLife has a market capitalization of $634.50 million and generates $276.22 million in revenue each year. The medical equipment provider earns $1.72 million in net income (profit) each year or $0.31 on an earnings per share basis. CryoLife employs 1,200 workers across the globe.

What is CryoLife's official website?

The official website for CryoLife is www.cryolife.com.

How can I contact CryoLife?

CryoLife's mailing address is 1655 Roberts Boulevard N.W, Kennesaw GA, 30144. The medical equipment provider can be reached via phone at 770-419-3355 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.